In conclusion, in this scoping review of GT/C for breast cancer in women of African heritage, we identified a growing body of literature that was conducted predominantly in the United States by researchers in the United States Approximately half of the studies carried out GT, most commonly of BRCA1 and BRCA2, while one third conducted GC. The gene discussed is BRCA1; the disease is breast cancer.